Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works

Angiogenesis in health and disease

Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,258 · see citing works

Hearing loss and cognitive decline in older adults

Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017 · see citing works

Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Pericytes regulate the blood–brain barrier

Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · see citing works

Neurovascular regulation in the normal brain and in Alzheimer's disease

Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · see citing works

Pericytes are required for blood–brain barrier integrity during embryogenesis

Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128 · see citing works

Blood-brain barrier breakdown in the aging human hippocampus

Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102 · see citing works

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works

Capillary pericytes regulate cerebral blood flow in health and disease

Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., O’Farrell, F. M., Buchan, A. M., Lauritzen, M., & Attwell, D. (2014) · Nature · doi:10.1038/nature13165 · Cited by 1,870 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

The Pathobiology of Vascular Dementia

Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857 · see citing works

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426 · see citing works

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation

Wang, E., Yao, H.-B., Chen, Y., Wang, G., Gao, W., Sun, Y., Guo, J., Hu, J., Jiang, C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,176 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X., Wenk, M. R., Goh, E. L. K., & Silver, D. L. (2014) · Nature · doi:10.1038/nature13241 · Cited by 1,048 · see citing works

Mfsd2a is critical for the formation and function of the blood-brain barrier

Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037 · see citing works

2014 Alzheimer's disease facts and figures

Alzheimer's Association (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,032 · see citing works

Central nervous system pericytes in health and disease

Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962 · see citing works

Neurovascular mechanisms of Alzheimer's neurodegeneration

Zloković, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 921 · see citing works

Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice

Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I. S., Korade-Mirnics, Z., Lee, V. M.-Y., Hersh, L. B., Sapolsky, R. M., Mirnics, K., & Sisodia, S. S. (2005) · Cell · doi:10.1016/j.cell.2005.01.015 · Cited by 885 · see citing works

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849 · see citing works

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833 · see citing works

LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms

Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828 · see citing works

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801 · see citing works

The Genetics of Alzheimer's Disease

Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 784 · see citing works

Crystal structure of the human glucose transporter GLUT1

Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N. (2014) · Nature · doi:10.1038/nature13306 · Cited by 777 · see citing works

apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain

Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works

Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study

Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733 · see citing works

The genetics of Alzheimer disease

Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727 · see citing works

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · see citing works

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702 · see citing works

Alzheimer disease and cerebrovascular pathology: an update

Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · see citing works

Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670 · see citing works

Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649 · see citing works

A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease

Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619 · see citing works

Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience

Johnson, N. A., Jahng, G., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno‐Tempini, M. L., & Schuff, N. W. (2005) · Radiology · doi:10.1148/radiol.2343040197 · Cited by 580 · see citing works

Hypertension and Cerebrovascular Dysfunction

Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557 · see citing works

Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in <scp>A</scp> lzheimer's Disease

Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553 · see citing works

Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

Deane, R., Bell, R. D., Sagare, A. P., & Zloković, B. V. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 549 · see citing works

Glial influence on the blood brain barrier

Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 542 · see citing works

Intrathecal inflammation precedes development of Alzheimer's disease

Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · see citing works

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease

Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490 · see citing works

Microvascular injury and blood–brain barrier leakage in Alzheimer's disease

Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487 · see citing works

Alzheimer’s Disease Genetics: From the Bench to the Clinic

Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473 · see citing works

Cerebral microinfarcts: the invisible lesions

Smith, E. E., Schneider, J. A., Wardlaw, J. M., & Greenberg, S. M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70307-6 · Cited by 456 · see citing works

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447 · see citing works

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology

Schneider, J. A., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000118211.78503.f5 · Cited by 436 · see citing works

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434 · see citing works

A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain

Ryu, J. K., & McLarnon, J. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00434.x · Cited by 406 · see citing works

Microinfarct Pathology, Dementia, and Cognitive Systems

Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404 · see citing works

Oxidative stress signalling in Alzheimer's disease

Zhu, X., Raina, A. K., Lee, H., Casadesús, G., Smith, M. A., & Perry, G. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.012 · Cited by 390 · see citing works

Preventing Alzheimer’s Disease

Selkoe, D. J. (2012) · Science · doi:10.1126/science.1228541 · Cited by 378 · see citing works

Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II–induced aortic aneurysms

Satoh, K., Nigro, P., Matoba, T., O’Dell, M. R., Cui, Z., Shi, X., Mohan, A. M., Chen, Y., Abe, J., Illig, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1958 · Cited by 374 · see citing works

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography

Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U., Brooks, D. J., Owenius, R., Hägerström, D., Wollmer, P., Minthon, L., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1358 · Cited by 368 · see citing works

Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia

Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · see citing works

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Vanderstichele, H., Bibl, M., Engelborghs, S., Le Bastard, N., Lewczuk, P., Molinuevo, J. L., Parnetti, L., Perret‐Liaudet, A., Shaw, L. M., Teunissen, C., et al. (2012) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2011.07.004 · Cited by 358 · see citing works

Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults

Brickman, A. M., Khan, U., Provenzano, F. A., Yeung, L., SUZUKI, W. A., Schroeter, H., Wall, M. M., Sloan, R. P., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3850 · Cited by 349 · see citing works

Effectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging

Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348 · see citing works

New Insights into the Dementia Epidemic

Larson, E. B., Yaffe, K. S., & Langa, K. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1311405 · Cited by 347 · see citing works

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Sirén, A.-L., Pardo, L. A., Sperling, S., Mohd Jofrry, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.110 · Cited by 342 · see citing works

Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease

Kalaria, R. N., & Harik, S. I. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07399.x · Cited by 338 · see citing works

Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis

Small, S. A., & Gandy, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.001 · Cited by 320 · see citing works

Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

Paul, J., Strickland, S., & Melchor, J. P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070304 · Cited by 319 · see citing works

The future of blood‐based biomarkers for Alzheimer's disease

Henriksen, K., O’Bryant, S. E., Hampel, H. J., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H. D., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 312 · see citing works

Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00994.x · Cited by 307 · see citing works

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy

Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297 · see citing works

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289 · see citing works

Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment

Hampel, H., Teipel, S. J., Fuchsberger, T., Andreasen, N., Wiltfang, J., Otto, M., Shen, Y., Dodel, R., Du, Y., Farlow, M., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001473 · Cited by 287 · see citing works

Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280 · see citing works

The Pericyte: A Forgotten Cell Type with Important Implications for A lzheimer's Disease?

Winkler, E. A., Sagare, A. P., & Zloković, B. V. (2014) · Brain Pathology · doi:10.1111/bpa.12152 · Cited by 275 · see citing works

Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer’s Disease Detected in vivo with Magnetic Resonance Imaging

Raven, E. P., Lu, P. H., Tishler, T. A., Heydari, P., & Bartzokis, G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130209 · Cited by 270 · see citing works

Untitled work

(2006) · PubMed · Cited by 269 · see citing works

Cerebrovascular Effects of Apolipoprotein E: Implications for Alzheimer Disease

Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2152 · Cited by 263 · see citing works

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

Büerger, K., Teipel, S. J., Zinkowski, R. P., Blennow, K., Arai, H., Engel, R. R., Hofmann‐Kiefer, K., McCulloch, C., Ptok, U., Heun, R., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.627 · Cited by 255 · see citing works

DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial

Stonehouse, W., Conlon, C. A., Podd, J., Hill, S. R., Minihane, A. M., Haskell, C., & Kennedy, D. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.053371 · Cited by 252 · see citing works

The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease

Mrak, R. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00293-7 · Cited by 248 · see citing works

Untitled work

(2014) · Research Portal (King's College London) · Cited by 246 · see citing works

A population study on blood-brain barrier function in 85-year-olds

Skoog, I. G., Wallin, A., Fredman, P., Hesse, C., Aevarsson, Ó., Karlsson, I., Gottfries, C. G., & Blennow, K. (1998) · Neurology · doi:10.1212/wnl.50.4.966 · Cited by 241 · see citing works

Does vascular pathology contribute to Alzheimer changes?

Kalaria, R. N., Akinyemi, R., & Ihara, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.032 · Cited by 238 · see citing works

Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

Winkler, E. A., Sengillo, J. D., Sagare, A. P., Zhao, Z., Ma, Q., Zuniga, E., Wang, Y., Zhong, Z., Sullivan, J. S., Griffin, J. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401595111 · Cited by 238 · see citing works

Measurement of brain perfusion, blood volume, and blood‐brain barrier permeability, using dynamic contrast‐enhanced T1‐weighted MRI at 3 tesla

Larsson, H., Courivaud, F., Rostrup, E., & Hansen, A. E. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22136 · Cited by 236 · see citing works

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

Craig‐Schapiro, R., Kühn, M., Xiong, C., Pickering, E. H., Liu, J., Misko, T. P., Perrin, R. J., Bales, K. R., Soares, H. D., Fagan, A. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018850 · Cited by 235 · see citing works

Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

Cramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · see citing works

Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability

Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., & Zlokovic, B. V. (2012) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2012.113 · Cited by 226 · see citing works

Cerebral Blood Flow Measured by Arterial Spin Labeling MRI as a Preclinical Marker of Alzheimer's Disease

Wierenga, C. E., Hays, C. C., & Zlatar, Z. Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141467 · Cited by 224 · see citing works

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Roe, C. M., Fagan, A. M., Grant, E. A., Hassenstab, J., Moulder, K. L., Maue Dreyfus, D., Sutphen, C. L., Benzinger, T. L. S., Mintun, M. A., Holtzman, D. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182918ca6 · Cited by 222 · see citing works

LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β

Kanekiyo, T., Liu, C., Shinohara, M., Li, J., & Bu, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 221 · see citing works

Diffusion tensor imaging of white matter degeneration in Alzheimer’s disease and mild cognitive impairment

Amlien, I. K., & Fjell, A. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.017 · Cited by 219 · see citing works

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

Niwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218 · see citing works

Biomarkers of Alzheimer's disease

Craig‐Schapiro, R., Fagan, A. M., & Holtzman, D. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.003 · Cited by 217 · see citing works

ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function

Suh, J., Choi, S. H., Romano, D. M., Gannon, M. A., Lesinski, A. N., Kim, D. Y., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.08.035 · Cited by 217 · see citing works

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

Peskind, E. R., Griffin, W. S. T., Akama, K. T., Raskind, M. A., & Eldik, L. J. V. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00048-1 · Cited by 215 · see citing works

Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition

Goos, J. D. C., Kester, M. I., Barkhof, F., Klein, M., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.109.558197 · Cited by 213 · see citing works

Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization

Ahn, H. J., Zamolodchikov, D., Cortés‐Canteli, M., Norris, E. H., Glickman, J. F., & Strickland, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010373107 · Cited by 211 · see citing works

APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging

Thambisetty, M., Beason‐Held, L. L., An, Y., Kraut, M. A., & Resnick, S. M. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.913 · Cited by 211 · see citing works

Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease

Mori, T., Koyama, N., Arendash, G. W., Horikoshi‐Sakuraba, Y., Tan, J., & Town, T. (2009) · Glia · doi:10.1002/glia.20924 · Cited by 207 · see citing works

GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease

Mooradian, A. D., Chung, H. C., & Shah, G. N. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00111-5 · Cited by 199 · see citing works

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo, J. L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret‐Liaudet, A., Teunissen, C. E., & Parnetti, L. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.003 · Cited by 198 · see citing works

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Hu, W. T., Chen‐Plotkin, A. S., Arnold, S. E., Grossman, M., Clark, C. M., Shaw, L. M. J., Pickering, E. H., Kühn, M., Chen, Y., McCluskey, L. F., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0667-0 · Cited by 196 · see citing works

Cerebral blood flow in Alzheimer’s disease

Roher, A., Debbins, J., Malek-Ahmadi, M., Chen, K.-W., Pipe, J., Maze, S., Belden, C. M., Maarouf, C., Thiyyagura, P., Mo, H., et al. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s34874 · Cited by 194 · see citing works

Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease

Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., & Avison, M. J. (1999) · Neurology · doi:10.1212/wnl.53.7.1391 · Cited by 194 · see citing works

Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study

Starr, J. M., Farrall, A., Armitage, P. A., McGurn, B., & Wardlaw, J. M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.04.003 · Cited by 192 · see citing works

Neurodegeneration and the neurovascular unit

Zloković, B. V. (2010) · Nature Medicine · doi:10.1038/nm1210-1370 · Cited by 190 · see citing works

Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study

Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C. E., Nelson, S. K., Williams, S., Hodges, A., Johnston, C., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130380 · Cited by 187 · see citing works

Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies

Jagust, W. J., Seab, J. P., Huesman, R. H., Valk, P. E., Mathis, C. A., Reed, B., Coxson, P. G., & Budinger, T. F. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.65 · Cited by 187 · see citing works

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Galasko, D. R., Bell, J. S., Mancuso, J. Y., Kupiec, J. W., Sabbagh, M. N., van Dyck, C. H., Thomas, R. G., Aisen, P. S. S., & Study, F. T. A. D. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000364 · Cited by 187 · see citing works

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

Blennow, K., Wallin, A., Fredman, P., Karlsson, I., Gottfries, C. G., & Svennerholm, L. T. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01563.x · Cited by 185 · see citing works

White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors

Blennow, K., Wallin, A., Uhlemann, C., & Gottfries, C. G. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04675.x · Cited by 185 · see citing works

The <i>APOE</i> ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

Hultman, K., Strickland, S., & Norris, E. H. (2013) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2013.76 · Cited by 183 · see citing works

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

Sjögren, M., Rosengren, L., Minthon, L., Davidsson, P., Blennow, K., & Wallin, A. (2000) · Neurology · doi:10.1212/wnl.54.10.1960 · Cited by 181 · see citing works

Dense-Core Plaques in Tg2576 and PSAPP Mouse Models of Alzheimer's Disease Are Centered on Vessel Walls

Kumar‐Singh, S., Pirici, D. N., McGowan, E. M., Serneels, S., Ceuterick, C., Hardy, J., Duff, K., Dickson, D. W., & Broeckhoven, C. V. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62995-1 · Cited by 179 · see citing works

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179 · see citing works

Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele

Hawkes, C. A., Sullivan, P. M., Hands, S. L., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041636 · Cited by 177 · see citing works

Developing novel blood‐based biomarkers for Alzheimer's disease

Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sj⊘gren, M., et al. (2014) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2013.10.007 · Cited by 177 · see citing works

The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia

DeFina, L. F., Willis, B. L., Radford, N. B., Gao, A., Leonard, D. S., Haskell, W. L., Weiner, M., & Berry, J. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00005 · Cited by 170 · see citing works

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

Liguori, C., Stefani, A., Sancesario, G., Sancesario, G., Marciani, M. G., & Pierantozzi, M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308577 · Cited by 162 · see citing works

Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease

Protas, H. D., Chen, K., Langbaum, J. B. S., Fleisher, A. S., Alexander, G. E., Lee, W., Bandy, D., de Leon, M. J., Mosconi, L., Buckley, S., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.286 · Cited by 161 · see citing works

Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice

Alata, W., Ye, Y., St‐Amour, I., Vandal, M., & Calon, F. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.172 · Cited by 160 · see citing works

The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy

Baloyannis, S. J., & Baloyannis, I. S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.010 · Cited by 150 · see citing works

Inhibition of Angiogenesis by Aβ Peptides

Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., DelleDonne, A., Patel, N., Obregon, D. F., et al. (2004) · Angiogenesis · doi:10.1023/b:agen.0000037335.17717.bf · Cited by 148 · see citing works

Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis

Liu, R., Wu, C., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T., & Du, G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-105 · Cited by 141 · see citing works

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

Apostolova, L. G., Hwang, K., Andrawis, J. P., Green, A. E., Babakchanian, S., Morra, J. H., Cummings, J. L., Toga, A. W., Trojanowski, J. Q., Shaw, L. M. J., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.003 · Cited by 137 · see citing works

Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex

Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137 · see citing works

The Neurovascular Unit in Health and Disease

Lo, E. H., & Rosenberg, G. A. (2008) · Stroke · doi:10.1161/strokeaha.108.534404 · Cited by 135 · see citing works

Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging.

Haacke, E. M., DelProposto, Z., Chaturvedi, S., Sehgal, V., Tenzer, M., Neelavalli, J., & Kido, D. K. (2007) · PubMed Central · Cited by 135 · see citing works

Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis

Paris, D., Patel, N. S., DelleDonne, A., Quadros, A., Smeed, R., & MULLAN, M. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.017 · Cited by 133 · see citing works

Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.

Piert, M., Koeppe, R. A., Giordani, B., Berent, S., & KUHL, D. E. (1996) · PubMed · Cited by 131 · see citing works

Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier

Zloković, B. V. (1995) · Pharmaceutical Research · doi:10.1023/a:1016254514167 · Cited by 131 · see citing works

Innate immunity receptor CD36 promotes cerebral amyloid angiopathy

Park, L., Zhou, J., Zhou, P., Pistick, R., Jamal, S. E., Younkin, L. H., Pierce, J. P., Arreguin, A. J., Anrather, J., Younkin, S. G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300021110 · Cited by 130 · see citing works

Recommendations of the Alzheimer's Disease–Related Dementias Conference

Montine, T. J., Koroshetz, W. J., Babcock, D., Dickson, D. W., Galpern, W. R., Glymour, M. M., Greenberg, S. M., Hutton, M. L., Knopman, D. S., Kuzmichev, A. N., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000733 · Cited by 123 · see citing works

Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain

Saeed, A. A., Genové, G., Li, T. X., Lütjohann, D., Olin, M., Mast, N., Pikuleva, I. A., Crick, P. J., Wang, Y., Griffiths, W. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556159 · Cited by 121 · see citing works

Glut1/SLC2A1 is crucial for the development of the blood‐brain barrier in vivo

Zheng, P., Romme, E., van der Spek, P. J., Dirven, C. M. F., Willemsen, R., & Kros, J. M. (2010) · Annals of Neurology · doi:10.1002/ana.22318 · Cited by 119 · see citing works

Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown

Halliday, M. R., Pomara, N., Sagare, A. P., Mack, W. J., Frangione, B., & Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3841 · Cited by 119 · see citing works

Transport of Leucine‐Enkephalin Across the Blood‐Brain Barrier in the Perfused Guinea Pig Brain

Zloković, B. V., Lipovac, M. N., Begley, D. J., Davson, H., & Rakić, L. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03431.x · Cited by 118 · see citing works

Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease

Fonteh, A. N., Cipolla, M., Chiang, J., Arakaki, X., & Harrington, M. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100519 · Cited by 116 · see citing works

S100β Induction of the Proinflammatory Cytokine Interleukin‐6 in Neurons

Li, Y., Barger, S. W., Liu, L., Mrak, R. E., & Griffin, W. S. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740143.x · Cited by 115 · see citing works

Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease

Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.499 · Cited by 115 · see citing works

Blood-brain barrier permeability to leucine-enkephalin,d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine)

Zlokovic, B. V., Begley, D. J., & Chain-Eliash, D. G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90423-8 · Cited by 114 · see citing works

Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele

Suri, S., Mackay, C. E., Kelly, M. E., Germuska, M. A., Tunbridge, E. M., Frisoni, G. B., Matthews, P. M., Ebmeier, K. P., Bulte, D. P., & Filippini, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1755 · Cited by 113 · see citing works

Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease

Salloway, S., Gur, T., Berzin, T., Zipser, B., Correia, S., Hovanesian, V, Fallon, J., Kuo-Leblanc, V, Glass, D., Hulette, C., et al. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00288-5 · Cited by 113 · see citing works

Differential effect of <i>APOE</i> genotype on amyloid load and glucose metabolism in AD dementia

Ossenkoppele, R., van der Flier, W. M., Zwan, M. D., Adriaanse, S. F., Boellaard, R., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., & van Berckel, B. N. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0889 · Cited by 112 · see citing works

Reduction in DHA transport to the brain of mice expressing human APOE 4 compared to APOE 2

Vandal, M., Alata, W., Tremblay, C., Rioux‐Perreault, C., Salem, N., Calon, F., & Plourde, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12640 · Cited by 109 · see citing works

Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1

Dömötör, E. (2003) · Blood · doi:10.1182/blood-2002-12-3680 · Cited by 108 · see citing works

Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping

Taheri, S., Gasparovic, C., Shah, N. J., & Rosenberg, G. A. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22686 · Cited by 107 · see citing works

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

Monro, O. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00317-7 · Cited by 107 · see citing works

Distribution of Glut1 Glucose Transporters in Different Brain Structures Compared to Glucose Utilization and Capillary Density of Adult Rat Brains

Zeller, K., Rahner-Welsch, S., & Kuschinsky, W. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199702000-00010 · Cited by 106 · see citing works

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults

Nation, D. A., Edland, S. D., Bondi, M. W., Salmon, D. P., Delano‐Wood, L., Peskind, E. R., Quinn, J. F., & Galasko, D. R. (2013) · Neurology · doi:10.1212/01.wnl.0000436935.47657.78 · Cited by 106 · see citing works

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients

Hu, Y., Shanshu, H., Wang, X., Duan, Q., Khatoon, S., Iqbal, K., Grundke, I., & Wang, J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00047-2 · Cited by 106 · see citing works

Vascular volume and blood‐brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls

Wang, H., Golob, E. J., & Su, M. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20669 · Cited by 106 · see citing works

A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer’s disease mice

Ahn, H. J., Glickman, J. F., Poon, K., Zamolodchikov, D., Jno-Charles, O. C., Norris, E. H., & Strickland, S. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131751 · Cited by 101 · see citing works

Multiple Microbleeds are Related to Cerebral Network Disruptions in Patients with Early Alzheimer's Disease

Heringa, S. M., on behalf of the Utrecht Vascular Cognitive Impairment (VCI) Study Group, Reijmer, Y. D., Leemans, A., Koek, H. L., Kappelle, L. J., & Biessels, G. J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130542 · Cited by 100 · see citing works

Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease

Horwood, N., & Davies, D. C. (1994) · Virchows Archiv · doi:10.1007/bf00193951 · Cited by 97 · see citing works

Cerebrospinal fluid tau, Aβ1–42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia

Jia, J., Meng, R., Sun, Y., Sun, W., Ji, X., & Jia, L. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.051 · Cited by 96 · see citing works

Detection of isolated cerebrovascular β‐amyloid with pittsburgh compound B

Greenberg, S. M., Grabowski, T. J., Gurol, M. E., Skehan, M. E., Nandigam, R. N. K., Becker, J. A., Garcı́a-Alloza, M., Prada, C. M., Frosch, M. P., Rosand, J. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21528 · Cited by 96 · see citing works

Decline of immune responsiveness: A pathogenetic factor in Alzheimer’s disease?

Richartz, E., Stransky, E., Batra, A., Simon, P. D., Lewczuk, P., Buchkremer, G., BARTELS, M., & Schott, K. J. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.12.005 · Cited by 95 · see citing works

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18–23, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7–12, 1998, Los Angeles, CA, USA.1

Hampel, H. J., Teipel, S. J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M., Kötter, H. U., Scheloske, M., Buch, K., Stübner, S., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01146-4 · Cited by 93 · see citing works

Age-Related Vascular Pathology in Transgenic Mice Expressing Presenilin 1-Associated Familial Alzheimer's Disease Mutations

Gama Sosa, M. A., Gasperi, R. D., Rocher, A. B., Wang, A. C.-J., Janssen, W. G. M., Flores, T., Perez, G. M., Schmeidler, J., Dickstein, D. L., Hof, P. R., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090482 · Cited by 92 · see citing works

Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone

Zloković, B. V., Segal, M. B., Begley, D. J., Davson, H., & Rakić, L. (1985) · Brain Research · doi:10.1016/0006-8993(85)90963-1 · Cited by 92 · see citing works

Injury and repair in the neurovascular unit

Xing, C., Hayakawa, K., Lok, J. M., Arai, K., & Lo, E. H. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000019 · Cited by 91 · see citing works

Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice

Toneatto, S., Finco, O., van der Putten, H., Abrignani, S., & Annunziata, P. (1999) · AIDS · doi:10.1097/00002030-199912030-00005 · Cited by 91 · see citing works

Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow

Li, H., Guo, Q., Inoue, T., Polito, V. A., Tabuchi, K., Hammer, R. E., Pautler, R. G., Taffet, G. E., & Zheng, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-28 · Cited by 86 · see citing works

Reduction of Amyloid Angiopathy and Aβ Plaque Burden after Enriched Housing in TgCRND8 Mice

Ambrée, O., Leimer, U., Herring, A., Goertz, N., Sachser, N., Heneka, M. T., Paulus, W., & Keyvani, K. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051107 · Cited by 85 · see citing works

Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease

Jefferies, W. A., Price, K. A., Biron, K. E., Fenninger, F., Pfeifer, C. G., & Dickstein, D. L. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt230 · Cited by 85 · see citing works

Activated protein C: Potential therapy for severe sepsis, thrombosis, and stroke

Griffin, J. H., Zloković, B. V., & Fernández, J. A. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.34093 · Cited by 84 · see citing works

Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon

Mann, G. E., Zlokovic, B. V., & Yudilevich, D. L. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90179-8 · Cited by 84 · see citing works

Clinical Predictors of Severe Cerebral Amyloid Angiopathy and Influence ofAPOEGenotype in Persons With Pathologically Verified Alzheimer Disease

Ringman, J. M., Sachs, M. C., Zhou, Y. F., Monsell, S. E., Saver, J. L., & Vinters, H. V. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.681 · Cited by 82 · see citing works

Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease

Sagare, A. P., Deane, R., Zetterberg, H., Wallin, A., Blennow, K., & Zloković, B. V. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101248 · Cited by 80 · see citing works

Chemokines in CSF of Alzheimer's disease patients

Corrêa, J. D., Starling, D. S. V., Teixeira, A. L., Caramelli, P., & Silva, T. A. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000400009 · Cited by 80 · see citing works

Soluble adhesion molecules and angiotensin-converting enzyme in dementia

Nielsen, H. M., Londos, E., Minthon, L., & Janciauskiene, S. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.011 · Cited by 80 · see citing works

Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease

Zhan, X., Jickling, G. C., Ander, B. P., Liu, D., Stamova, B. S., Cox, C. D., Jin, L. W., DeCarli, C. S., & Sharp, F. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140131120922 · Cited by 79 · see citing works

Pinocembrin attenuates blood–brain barrier injury induced by global cerebral ischemia–reperfusion in rats

Meng, F., Liu, R., Gao, M., Wang, Y., Yu, X., Xuan, Z.-H., Sun, J., Yang, F., Wu, C., & Du, G. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.010 · Cited by 79 · see citing works

Prevalence of cortical superficial siderosis in a memory clinic population

Zonneveld, H. I., Goos, J. D. C., Wattjes, M. P., Prins, N. D., Scheltens, P., van der Flier, W. M., Kuijer, J. P. A., Muller, M., & Barkhof, F. (2014) · Neurology · doi:10.1212/wnl.0000000000000150 · Cited by 78 · see citing works

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly

Glodzik, L., Mosconi, L., Tsui, W., Santi, S. D., Zinkowski, R. P., Pirraglia, E., Rich, K. E., McHugh, P. F., Li, Y., Williams, S., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.012 · Cited by 78 · see citing works

Glucose transporter plasticity during memory processing

Choeiri, C., Staines, W. A., Miki, T., Seino, S., & Messier, C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.011 · Cited by 76 · see citing works

Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly

Glodzik, L., Rusinek, H., Pirraglia, E., McHugh, P. F., Tsui, W., Williams, S., Cummings, M., Li, Y., Rich, K. E., Randall, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.011 · Cited by 76 · see citing works

Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease

Popp, J., Lewczuk, P., Kölsch, H., Meichsner, S., Maier, W., Kornhuber, J., Jessen, F., & Lütjohann, D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07893.x · Cited by 75 · see citing works

Environmental Enrichment Counteracts Alzheimer’s Neurovascular Dysfunction in TgCRND8 Mice

Herring, A., Yasin, H., Ambrée, O., Sachser, N., Paulus, W., & Keyvani, K. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00094.x · Cited by 73 · see citing works

Apolipoprotein A ‐ I : Insights from redox proteomics for its role in neurodegeneration

Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Rukhsana Sultana, A., & Butterfield, D. A. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200087 · Cited by 73 · see citing works

Innate Immunity in Alzheimer’s Disease: A Complex Affair

Guillot‐Sestier, M., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 71 · see citing works

Biomarkers in Alzheimer's Disease: Past, Present and Future

Gustaw‐Rothenberg, K., Lerner, A. J., Bonda, D., Lee, H., Zhu, X., Perry, G. L., & Smith, M. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.86 · Cited by 71 · see citing works

Immunohistochemical and Ultrastructural Studies

Kikuchi, A., Akiyama, M., Hanyaku, H., Shimizu, H., Naka, W., & Nishikawa, T. (1993) · American Journal of Dermatopathology · doi:10.1097/00000372-199302000-00003 · Cited by 71 · see citing works

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

Yamada, K., Kono, K., Umegaki, H., Yamada, K., Iguchi, A., Fukatsu, T., Nakashima, N., Nishiwaki, H., Shimada, Y., Sugita, Y., et al. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11318-q · Cited by 70 · see citing works

Unchanged levels of interleukins, neopterin, interferon-γ and tumor necrosis factor-α in cerebrospinal fluid of patients with dementia of the Alzheimer type

Engelborghs, S., Brabander, M. D., Crée, J. D., D’Hooge, R., Geerts, H., Verhaegen, H., & Deyn, P. P. D. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00031-5 · Cited by 69 · see citing works

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease

Schmidt, F. M., Mergl, R., Stach, B., Jahn, I., Gertz, H., & Schönknecht, P. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.007 · Cited by 67 · see citing works

Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents

Mosconi, L., Rinne, J. O., Tsui, W. H., Murray, J., Li, Y., Glodzik, L., McHugh, P. F., Williams, S., Cummings, M., Pirraglia, E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.002 · Cited by 66 · see citing works

Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches

Broeck, B. V., Broeckhoven, C. V., & Kumar‐Singh, S. (2007) · Neurodegenerative Diseases · doi:10.1159/000105156 · Cited by 65 · see citing works

Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid

Hanzel, C. E., Iulita, M. F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., & Cuello, A. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132282 · Cited by 64 · see citing works

Dissociable Effects of Alzheimer Disease and White Matter Hyperintensities on Brain Metabolism

Haight, T. J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1878 · Cited by 63 · see citing works

[15 years later].

Sanfeliu, V., Elías, A. R., Figueras, D., Verdura, T., Gelabert, M. L., Pique, J., Torra, J. E., Esteve, N., & Nadal, M. J. N. (1993) · PubMed · Cited by 61 · see citing works

Blood-Brain Barrier: A Dual Life of MFSD2A?

Zhao, Z., & Zlokovic, B. V. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.012 · Cited by 59 · see citing works

Markedly Elevated Soluble Intercellular Adhesion Molecule 1, Soluble Vascular Cell Adhesion Molecule 1 Levels, and Blood-Brain Barrier Breakdown in Neuromyelitis Optica

Uzawa, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.148 · Cited by 57 · see citing works

Neuron-Specific Enolase, S-100 Protein, Myelin Basic Protein and Lactate in CSF in Dementia

Nooijen, P. T. G. A., Schoonderwaldt, H. C., Wevers, R. A., Hommes, O. R., & Lamers, K. J. B. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106627 · Cited by 57 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works

Establishment and Dysfunction of the Blood-Brain Barrier

Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · see citing works

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243 · see citing works

Pericytes of the neurovascular unit: key functions and signaling pathways

Sweeney, M. D., Ayyadurai, S., & Zlokovic, B. V. (2016) · Nature Neuroscience · doi:10.1038/nn.4288 · Cited by 1,125 · see citing works

The role of brain vasculature in neurodegenerative disorders

Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998 · see citing works

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · see citing works

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604 · see citing works

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease

Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · see citing works

Neuronal regulation of the blood–brain barrier and neurovascular coupling

Kaplan, L., Chow, B. W., & Gu, C. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0322-2 · Cited by 431 · see citing works

Strategies for transporting nanoparticles across the blood–brain barrier

Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W. (2016) · Biomaterials Science · doi:10.1039/c5bm00383k · Cited by 308 · see citing works

Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults

Bowman, G. L., Dayon, L., Kirkland, R. E., Wojcik, J., Peyratout, G., Severin, I. C., Henry, H., Oikonomidi, A., Migliavacca, E., Bacher, M., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2857 · Cited by 296 · see citing works

The biological pathways of Alzheimer disease: a review

Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 271 · see citing works

Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

Elliott, R. O., & He, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010122 · Cited by 263 · see citing works

Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases

Sun, B., Wang, L.-H., Yang, T., Sun, J., Mao, L., Yang, M., Yuan, H., Colvin, R. A., & Yang, X. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.007 · Cited by 255 · see citing works

Brain imaging of neurovascular dysfunction in Alzheimer’s disease

Montagne, A., Nation, D. A., Pa, J., Sweeney, M. D., Toga, A. W., & Zlokovic, B. V. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1570-0 · Cited by 239 · see citing works

Vascular contributions to cognitive impairment, clinical Alzheimer’s disease, and dementia in older persons

Kapasi, A., & Schneider, J. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2015.12.023 · Cited by 200 · see citing works

Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease

Calderón‐Garcidueñas, L., Reynoso-Robles, R., Martínez, J. V., Chew, A. G. M., Pérez-Guillé, B., Mukherjee, P. S., Torres‐Jardón, R., Perry, G. L., & González-Maciel, A. (2016) · Environmental Research · doi:10.1016/j.envres.2015.12.031 · Cited by 176 · see citing works

Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events

Carvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 175 · see citing works

Vascular contributions to Alzheimer's disease

Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 179 · see citing works

Age‐related changes in cerebrovascular health and their effects on neural function and cognition: A comprehensive review

Zimmerman, B., Bart Rypma, A., Gratton, G., & Fabiani, M. (2021) · Psychophysiology · doi:10.1111/psyp.13796 · Cited by 173 · see citing works

Vascular Cognitive Impairment and Dementia

Wong, E. C., & Chui, H. C. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001124 · Cited by 158 · see citing works

Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment

Querques, G., Borrelli, E., Sacconi, R., Vitis, L. A. D., Leocani, L., Santangelo, R., Magnani, G., Comı, G., & Bandello, F. M. (2019) · Scientific Reports · doi:10.1038/s41598-018-37271-6 · Cited by 149 · see citing works

β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease

Li, J., Li, M., Ge, Y., Chen, J., Ma, J., Wang, C., Sun, M., Wang, L., Yao, S., & Yao, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00807-5 · Cited by 145 · see citing works

Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer’s Disease Development

González-Maciel, A., Reynoso-Robles, R., Torres‐Jardón, R., Mukherjee, P. S., & Calderón‐Garcidueñas, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170012 · Cited by 133 · see citing works

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

Skillbäck, T. B., Delsing, L., Synnergren, J., Mattsson, N., Janelidze, S., Nägga, K., Kilander, L., Hicks, R., Wimo, A. B., Winblad, B. G., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.028 · Cited by 123 · see citing works

The blood brain barrier in Alzheimer’s disease

Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118 · see citing works

Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms

Song, J., Lu, C. T., Leszek, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810118 · Cited by 95 · see citing works

Type 2 Diabetes Mellitus Increases the Risk of Late-Onset Alzheimer’s Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy

Hayden, M. R. (2019) · Brain Sciences · doi:10.3390/brainsci9100262 · Cited by 90 · see citing works

Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer’s disease

Montero‐Crespo, M., Domínguez-Álvaro, M., Alonso‐Nanclares, L., DeFelipe, J., & Blázquez‐Llorca, L. (2020) · Brain · doi:10.1093/brain/awaa406 · Cited by 88 · see citing works

Neural stem cell therapy for neurovascular injury in Alzheimer's disease

Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 88 · see citing works

Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links

He, J., Zhao, X., Xu, L., & Mao, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190764 · Cited by 86 · see citing works

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works

Alzheimer’s/Vascular Spectrum Dementia: Classification in Addition to Diagnosis

Emrani, S., Lamar, M., Price, C. C., Wasserman, V., Matusz, E. F., Au, R., Swenson, R. A., Nagele, R. G., Heilman, K. M., & Libon, D. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190654 · Cited by 76 · see citing works

Basal lamina changes in neurodegenerative disorders

Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75 · see citing works

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 79 · see citing works

The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives

Lucaciu, A., Brunkhorst, R., Pfeilschifter, J. M., Pfeilschifter, W., & Subburayalu, J. (2020) · Cells · doi:10.3390/cells9061515 · Cited by 65 · see citing works

The application of optical coherence tomography angiography in Alzheimer's disease: A systematic review

Rifai, O. M., McGrory, S., Robbins, C. B., Grewal, D. S., Liu, A., Fekrat, S., & MacGillivray, T. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12149 · Cited by 64 · see citing works

Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer’s Disease Model Mouse

Shang, J., Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., & Abe, K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151126 · Cited by 64 · see citing works

Headaches and Risk of Dementia

Tzeng, N., Chung, C., Lin, F., Yeh, C., Huang, S., Lu, R., Chang, H., Kao, Y., Chiang, W.-S., Chou, Y., et al. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.12.014 · Cited by 62 · see citing works

Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood–Brain Barrier Transmitters

Amiri, M., Jafari, S., Kurd, M., Mohamadpour, H., Khayati, M., Ghobadinezhad, F., Tavallaei, O., Derakhshankhah, H., Malvajerd, S. S., & Izadi, Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00540 · Cited by 61 · see citing works

A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model

Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58 · see citing works

Folate nutrition and blood–brain barrier dysfunction

Stover, P. J., Durga, J., & Field, M. S. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.01.006 · Cited by 59 · see citing works

The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review

Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C. G., Griffin, R. C., & Galletly, C. A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112541 · Cited by 55 · see citing works

Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities

Zhang, R., Song, Y., & Su, X. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220809 · Cited by 53 · see citing works

The role of neurovascular unit damage in the occurrence and development of Alzheimer’s disease

Liu, X., Hou, D., Lin, F., Luo, J., Xie, J., Wang, Y., & Tian, Y. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0056 · Cited by 53 · see citing works

Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β‐amyloid fibrinogen interaction

Chung, Y. C., Kruyer, A., Yao, Y., Feierman, E. R., Richards, A., Strickland, S., & Norris, E. H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13340 · Cited by 49 · see citing works

Pericytes Across the Lifetime in the Central Nervous System

Bennett, H. C., & Kim, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.627291 · Cited by 47 · see citing works

Recent Developments in Understanding Brain Aging: Implications for Alzheimer’s Disease and Vascular Cognitive Impairment

Deák, F., Freeman, W. M., Ungvari, Z. I., Csiszár, A., & Sonntag, W. E. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv206 · Cited by 44 · see citing works

Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression

Audrain, M., Fol, R. R., Dutar, P., Potier, B., Billard, J., Flament, J., Alves, S., Burlot, M., Dufayet‐Chaffaud, G., Bemelmans, A., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0070-y · Cited by 44 · see citing works

Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells

Lauschke, K., Frederiksen, L., & Hall, V. J. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0003 · Cited by 43 · see citing works

Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.

Mu, D., Guo, H., Zhou, G., Li, J., & Su, B. (2015) · PubMed Central · Cited by 40 · see citing works

MAGP2 controls Notch via interactions with RGD binding integrins: Identification of a novel ECM–integrin–Notch signaling axis

DeFord, P., Brown, K., Richards, R. L., King, A., Newburn, K., Westover, K., & Albig, A. R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.011 · Cited by 39 · see citing works

The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease

Padovani, A., Galli, A., Bazzoli, E., Tolassi, C., Caratozzolo, S., Gumina, B., Benussi, A., Libri, I., Outeiro, T. F., & Pilotto, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14556 · Cited by 37 · see citing works

Functional connectivity among brain regions affected in Alzheimer's disease is associated with CSF TNF-α in APOE4 carriers

Contreras, J. A., Aslanyan, V., Sweeney, M. D., Sanders, L. M. J., Sagare, A. P., Zloković, B. V., Toga, A. W., Han, S. D., Morris, J. C., Fagan, A. M., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.013 · Cited by 41 · see citing works

Interactions between Flow Oscillations and Biochemical Parameters in the Cerebrospinal Fluid

Puy, V., Zmudka-Attier, J., Capel, C., Bouzerar, R., Sérot, J., Bourgeois, A.-M., Ausseil, J., & Balédent, O. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00154 · Cited by 37 · see citing works

Impaired Folate-Mediated One-Carbon Metabolism in Type 2 Diabetes, Late-Onset Alzheimer’s Disease and Long COVID

Hayden, M. R., & Tyagi, S. (2021) · Medicina · doi:10.3390/medicina58010016 · Cited by 35 · see citing works

Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases

Curtis, C., Zhang, M., Liao, R., Wood, T. R., & Nance, E. A. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1422 · Cited by 32 · see citing works

Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects

Alkahtani, S. H., AL–Johani, N. S., & Alarifi, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021340 · Cited by 32 · see citing works

Role of membrane biophysics in Alzheimer's–related cell pathways

Zhu, D., Bungart, B. L., Yang, X., Zhumadilov, Z. S., Lee, J. C., & Askarova, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00186 · Cited by 32 · see citing works

Glycosylation of dentin matrix protein 1 is a novel key element for astrocyte maturation and BBB integrity

Jing, B., Zhang, C., Liu, X., Zhou, L., Liu, J., Yao, Y., Yu, J., Weng, Y., Pan, M., Liu, J., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0449-8 · Cited by 30 · see citing works

PRDM16 orchestrates angiogenesis via neural differentiation in the developing brain

Su, L., Lei, X., Ma, H., Feng, C., Jiang, J., & Jiao, J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0504-5 · Cited by 24 · see citing works

Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients

Grewal, R., Haghighi, M., Huang, S., Smith, A., Cao, C., Lin, X., Lee, D. C., Teten, N., Hill, A. M., & Selenica, M. B. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0211-0 · Cited by 25 · see citing works

Intracranial vascular flow oscillations in Alzheimer’s disease from 4D flow MRI

Rivera‐Rivera, L. A., Cody, K. A., Rutkowski, D. R., Cary, P., Eisenmenger, L. B., Rowley, H. A., Carlsson, C. M., Johnson, S. C., & Johnson, K. M. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102379 · Cited by 24 · see citing works

Acute effects of systemic inflammation upon the neuro-glial-vascular unit and cerebrovascular function

Brezzo, G., Simpson, J. E., Ameen‐Ali, K. E., Berwick, J., & Martin, C. J. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100074 · Cited by 22 · see citing works

Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease

Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 22 · see citing works

Revealing the mechanisms of blood–brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention

Yu, S., Chen, X., Yang, T., Cheng, J., Liu, E., Jiang, L., Song, M., Shu, H., & Ma, Y. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0040 · Cited by 23 · see citing works

Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer’s disease: an adrenergic approach

Li, S., Wang, C., Wang, Z., & Tan, J. (2021) · Aging · doi:10.18632/aging.203482 · Cited by 20 · see citing works

Dental deafferentation and brain damage: A review and a hypothesis

Jou, Y. (2018) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2018.01.013 · Cited by 20 · see citing works

Neurovascular Dysfunction in Diverse Communities With Health Disparities—Contributions to Dementia and Alzheimer’s Disease

Saiyasit, N., Butlig, E.-A. R., Chaney, S. D., Traylor, M. K., Hawley, N. A., Randall, R. B., Bobinger, H. V., Frizell, C. A., Trimm, F., Crook, E. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.915405 · Cited by 21 · see citing works

Single nuclei transcriptomics in diabetic mice reveals altered brain hippocampal endothelial cell function, permeability, and behavior

Nuthikattu, S., Milenković, D., Norman, J., & Villablanca, A. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166970 · Cited by 19 · see citing works

Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease: A Review

Doke, R. R., Lamkhade, G., Vinchurkar, K., & Singh, S. K. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00457 · Cited by 23 · see citing works

Cerebrovascular miRNAs correlate with the clearance of Aβ through perivascular route in younger 3xTg‐AD mice

Fu, L., Jiang, G., Weng, H., Dick, G. M., Chang, Y.-Z., & Kassab, G. S. (2019) · Brain Pathology · doi:10.1111/bpa.12759 · Cited by 20 · see citing works

Nanomedicine against Alzheimer’s and Parkinson’s Disease

Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 19 · see citing works

Recent progresses in natural based therapeutic materials for Alzheimer's disease

Zivari‐Ghader, T., Valioğlu, F., Eftekhari, A., Aliyeva, I., Beylerli, O., Davran, S., Cho, W. C. S., Beilerli, A., Khalilov, R. I., & Javadov, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26351 · Cited by 16 · see citing works

Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders

Libri, I., Silvestri, C., Caratozzolo, S., Alberici, A., Pilotto, A., Archetti, S., Trainini, L., Borroni, B., Padovani, A., & Benussi, A. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.04.003 · Cited by 16 · see citing works

The Role of Brain Barriers in Maintaining Brain Vitamin Levels

Tiani, K. A., Stover, P. J., & Field, M. S. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124235 · Cited by 14 · see citing works

Patient-specific computational fluid dynamic simulation of cerebrospinal fluid flow in the intracranial space

Fillingham, P., Levendovszky, S. R., Andre, J. B., Parsey, C. M., Bindschadler, M., Friedman, S. D., Kurt, M., Aliseda, A., & Levitt, M. R. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147962 · Cited by 14 · see citing works

On Validators for Psychiatric Categories

Solomon, M. (2022) · Philosophy of Medicine · doi:10.5195/pom.2022.74 · Cited by 14 · see citing works

Alteration of Vascular Endothelial Cadherin in Alzheimer’s Disease Patient and Mouse ModelPreprint

Lee, D., Cho, S., Lim, H. J., Seok, J., Jo, C., Jo, S. A., Park, M. H., Han, C., Kowall, N. W., Ryu, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/430140 · Cited by 13 · see citing works

Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery

Kirit, E., Gokce, C., Altun, B., & Yılmazer, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c02206 · Cited by 13 · see citing works

Iron Overload, Microbleeding and the Role of Bilirubin in Alzheimer’s Disease Brain: Revisiting the Vascular Hypothesis

Ficiarà, E., Rabbito, R., Roveta, F., Rubino, E., Rainero, I., Guiot, C., & Boschi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073060 · Cited by 12 · see citing works

Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide

Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12 · see citing works

Brain, Eyes, Light: Biological Electrical Magnetism of Light and Neurorehabilitation of Cognitive Impairment

Pyatin, V. F., Romanchuk, N., Иванович, Р. П., & Volobuev, A. N. (2019) · Bulletin of Science and Practice · doi:10.33619/2414-2948/49/14 · Cited by 11 · see citing works

Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer’s disease

Xie, R., Chen, F., Ma, Y., Hu, W., Zheng, Q., Cao, J., & Wu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1249632 · Cited by 11 · see citing works

Jiawei Xionggui Decoction promotes meningeal lymphatic vessels clearance of β-amyloid by inhibiting arachidonic acid pathway

Liu, X., Zhang, H., Xiang, J., Luo, W., Zhang, H., Wang, P., & Xu, S. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156041 · Cited by 11 · see citing works

Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?

Lu, D., Zhang, W., Li, R., Tan, S., & Zhang, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1499871 · Cited by 11 · see citing works

Nattokinase prevents β-amyloid peptide (Aβ1-42) induced neuropsychiatric complications, neuroinflammation and BDNF signalling disruption in mice

Naik, S. V., Katariya, R., Shelke, S., Patravale, V. B., Umekar, M. J., Kotagale, N. R., & Taksande, B. G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175821 · Cited by 10 · see citing works

Basic approach on the protective effects of hesperidin and naringin in Alzheimer’s disease

Kuşi, M., Becer, E., & Vatansever, S. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2397136 · Cited by 7 · see citing works

Vascular Dysfunction in the Brain; Implications for Heavy Metal Exposures

Olung, N. F., Aluko, O. M., Jeje, S. O., Adeagbo, A. S. O., & Ijomone, O. M. (2021) · Current Hypertension Reviews · doi:10.2174/1573402117666210225085528 · Cited by 7 · see citing works

Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function

Bae, J., Li, C., Masurkar, A. V., Ge, Y., & Kim, S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120284 · Cited by 7 · see citing works

Potential value of serum prealbumin and serum albumin in the identification of postoperative delirium in patients undergoing knee/hip replacement: an observational study and internal validation study

Wang, B., Xin, Y., Tang, X., Fei, W., Hua, S., Yang, Y.-C., Xu, S., Gong, H., Dong, R., Lin, Y., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1375383 · Cited by 6 · see citing works

Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition

Aso, Y., Kimura, N., & Matsubara, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215135 · Cited by 6 · see citing works

Putative Involvement of Cytokine Modulation in the Development of Perioperative Neurocognitive Disorders

Pereira, C., Dani, M., Taylor-Robinson, S. D., & Fertleman, M. B. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s364954 · Cited by 6 · see citing works

Traumatic brain injury and Alzheimer’s disease related neurodegenerative diseases: Insights from animal models

Zhao, X., & He, Z. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104979 · Cited by 5 · see citing works

Blocking α1 Adrenergic Receptor as a Novel Target for Treating Alzheimer’s Disease

Pan, X., Lei, Z., Chen, J., Jia, C., Deng, J., Liu, Y., Luo, X., Wang, L., Zi, D., Wang, Z., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00411 · Cited by 5 · see citing works

Hypertension accelerates cerebral tissue PO2 disruption in Alzheimer’s disease

Lu, X., Moeini, M., Li, B., Thorin, É., & Lesage, F. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134626 · Cited by 5 · see citing works

The immunomodulatory effects of psychedelics in Alzheimer’s disease-related dementia

Hosseini, A. M., Khaleghzadeh‐Ahangar, H., & Rahimi, A. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.062 · Cited by 4 · see citing works

OPEN REVIEW ARTICLE

(2016)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia

Llorens, F., Schmitz, M., Knipper, T., Schmidt, C., Lange, P., Fischer, A., Hermann, P., & Zerr, I. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00289 · Cited by 41 · see citing works

FTS3‐01‐03: Biomarkers for Vascular Contributions to Dementia

Scheltens, P., Blennow, K., Rowe, C. C., Fox, N. C., Lovestone, S., DeCarli, C. S., Snyder, H. M., Amouyel, P., & Carrillo, M. C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.2386

Associations between cerebrospinal fluid biomarkers related to endothelial dysfunction and Alzheimer’s disease

Zhu, Y.-K., Zhu, Q.-J., Wang, L. F., Hu, H., Wang, X.-J., Zhang, Z.-H., Zhang, W., Tan, L., & Hu, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1744647

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease

Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180 · see citing works